19
Feb 2026
Genome sequencing data reveals new insights into Epstein-Barr virus immunity
The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.
Stay Informed!
19
Feb 2026
Syzygium jambolanum extract shows promise for diabetes management
The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long history of traditional use.
19
Feb 2026
Exercise pills could offer new hope for depression treatment
We all know the feeling: the mental clarity that comes after a good run or a heavy workout. Science backs this up, even showing that for non-severe depression, exercise can be just as effective as antidepressants or therapy.
19
Feb 2026
Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk
An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up suggested durable immune memory with encouraging relapse-free outcomes, though controlled trials are needed to confirm clinical benefit.
19
Feb 2026
Cyborg transplants may advance cell-based therapies for diabetes
A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes.
19
Feb 2026
New guidelines outline comprehensive care for acute pulmonary embolism
Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life-threatening blood clot that blocks arteries in the lungs, is critical.
19
Feb 2026
MULTI-evolve accelerates protein engineering with machine learning
The search space for protein engineering grows exponentially with complexity. A protein of just 100 amino acids has 20^100 possible variants-more combinations than atoms in the observable universe.
19
Feb 2026
Study reveals long-term health risks after chemotherapy for testicular cancer
A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy regimens used to treat testicular cancer, highlighting differences in renal function, cardiovascular risk, and the overall burden of chronic health conditions among survivors.
19
Feb 2026
Blood test shows promise in forecasting outcomes for germ cell tumors
Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and Slovakia.
19
Feb 2026
CU Anschutz School of Medicine rises in national NIH funding rankings
The University of Colorado Anschutz School of Medicine continues to boost its standing in the Blue Ridge Institute for Medical Research (BRIMR) rankings, moving to No. 8 among public medical schools in the nation and to No. 21 among all medical schools, with half of its 18 clinical Departments landing in the top 15.
